Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Himgiri Pharma Ltd
NSE: HIMGIRIPHBSE: 514760Pharma Formulations
₹2,019.55
▲ 30.30 (+1.52%)
Profit & Loss
- FY22: 3,533
- FY23: 3,647
- FY24: 4,025
- FY25: 4,469
- FY26: 5,036
- FY22: 465
- FY23: 568
- FY24: 622
- FY25: 617
- FY26: 763
- FY22: ₹42.65
- FY23: ₹52.06
- FY24: ₹57.06
- FY25: ₹56.59
- FY26: ₹69.97
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 3,533 | 3,647 | 4,025 | 4,469 | 5,036 |
| Operating expenses | 2,710 | 2,671 | 3,005 | 3,433 | 3,806 |
| Operating profit (EBITDA) | 823 | 976 | 1,021 | 1,037 | 1,230 |
| Other income | 60 | 31 | 80 | 46 | 97 |
| Depreciation | 194 | 182 | 185 | 173 | 236 |
| Interest | 69 | 68 | 87 | 88 | 75 |
| Profit before tax | 620 | 757 | 829 | 822 | 1,017 |
| Tax | 155 | 189 | 207 | 206 | 254 |
| Net profit | 465 | 568 | 622 | 617 | 763 |
| EPS (₹) | 42.65 | 52.06 | 57.06 | 56.59 | 69.97 |
| Dividend per share (₹) | 13.42 | 16.39 | 17.96 | 17.81 | 22.03 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium